Hu Xinyu, Guo Kexin, Li Jingwen, Wang Xinyi, Liu Hanshu, Yu Qinwei, Kuang Guiying, Li Gang, Huang Jinsha, Li Hongge, Lin Zhicheng, Xiong Nian
Department of Neurology, Tongji Medical College, Union Hospital, Huazhong University of Science and Technology, Wuhan, China.
Department of Cardiology, Wuhan Red Cross Hospital, Wuhan, China.
Front Neurol. 2023 Jul 20;14:1171303. doi: 10.3389/fneur.2023.1171303. eCollection 2023.
Hemifacial spasm (HFS) is a rare movement disorder characterized by involuntary muscle contractions on one side of the face. Compared to the high therapeutic effect, adverse effects of botulinum toxin treatment for HFS occurred rarely. However, managing HFS patients who are also taking antithrombotic drugs poses a challenge. Here, we present a case of postoperative ecchymoma of the eyelid following a botulinum toxin injection in a patient receiving daily vinpocetine and aspirin antiplatelet therapy. This case highlights the importance of considering the potential risks and formulating a treatment plan that maximizes benefit while minimizing complications in HFS patients undergoing botulinum toxin injections and taking antithrombotic medications. To the best of our knowledge, this is the first reported case of postoperative ecchymoma of the eyelid following a botulinum toxin injection. Further research and additional case reports are needed to better understand the management strategies for this patient population.
面肌痉挛（HFS）是一种罕见的运动障碍，其特征为一侧面部肌肉不自主收缩。与肉毒杆菌毒素治疗HFS的高疗效相比，其不良反应很少发生。然而，管理同时服用抗血栓药物的HFS患者是一项挑战。在此，我们报告一例在接受长春西汀和阿司匹林每日抗血小板治疗的患者中，肉毒杆菌毒素注射后出现眼睑术后瘀斑瘤的病例。该病例强调了在接受肉毒杆菌毒素注射并服用抗血栓药物的HFS患者中，考虑潜在风险并制定使获益最大化同时将并发症降至最低的治疗方案的重要性。据我们所知，这是首例报道的肉毒杆菌毒素注射后眼睑术后瘀斑瘤病例。需要进一步研究和更多病例报告以更好地了解该患者群体的管理策略。
